Aclobet 0.05% Ointment 10 gm tube
Aclobet 0.05% Ointment 10 gm tubeCOMPOSITIONAclobet Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg.Aclobet Cream : Each gram contains Clobetasol Propionate BP 0.5 mg.PHARMACOLOGYClobetasol Propionate is a highly potent topical steroid. It has both local anti-inflammatory and immunosuppressive activity. Clobetasol, as the Propionate salt, is only used topically on the skin and its effects are limited to the local anti-inflammatory activity. When given systemically it has standard glucocorticoid activity and binds with high affinity to the glucocorticoid receptor. Clobetasol Propionate inhibits the adherence of neutrophils and monocyte-macrophages to the capillary endothelial cells inflammed area. Clobetasol blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin.INDICATIONSAclobet is indicated in :• Initial control of all forms of hyperacute eczema in all age groups (in children for no longer than a few days).• Chronic hyperkeratotic eczema of the hands and feet and patches of chronic lichen simplex.• Chronic hyperkeratotic psoriasis of any area of the body.• Severe acute photosensitivity.• Hypertrophic lichen planus.• Localized bullous disorders.• Keloid scarring.• Pretibial myxoedema.• Vitiligo.• Suppression of reaction after cryotherapy.DOSAGE AND ADMINISTRATIONRoute of AdministrationApply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations, therapy should be discontinued when control is achieved. If a longer course is necessary, it is recommended that treatment should not be continued for more than four weeks without the patients condition being observed. Repeated short courses of Aclobet may be used to control exacerbations. If continuous steroid treatment is necessary a less potent preparation should be used. In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effects of Aclobet can be enhanced, if necessary, by occluding the treatment area with polythene film. Only overnight occlusion is usually adequate to bring about a satisfactory response. Thereafter, improvement can usually be maintained by application without occlusion.CONTRAINDICATIONS AND PRECAUTIONClobetasol Propionate is contraindicated in :• Cutaneous infections such as impetigo, tinea corporis and herpes simplex.• Infestations such as scabies.• Neonates.• Acne Vulgaris.• Rosacea.• Gravitational ulceration.Long term continuous therapy with Clobetasol Propionate should be avoided, particularly in infants and children, in whom adrenal suppression occurs readily. If Clobetasol Propionate is required for use in children, it is recommended that the treatment should be reviewed on weekly basis. It should be noted that the infant’s napkin might act asocclusive dressing. The face more than other area of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids. This must be borne in mind when treating facial conditions which warrants use of Clobetasol Propionate and frequent observation of the patient is important.SIDE EFFECTSCommon side effects : Provided the weekly dosage is less then 50 g in adults, any pituitary adrenal suppression is likely to be transient with a rapid return to normal values once the short course of steroid therapy has ceased. The same applies to children given proportionate dosage. Use of occlusive dressings increases the absorption of topical corticosteroids. Prolonged and intensive treatment with a highly active corticosteroid preparation may cause atrophic changes, such as thinning, striae and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or where skin folds are involved.Rare side effects :USE IN PREGNANCY & LACTATIONClobetasol Propionate should be avoided in pregnant women. Mothers using large amounts of the drug should be aware of potential excretion in milk.USE IN CHILDREN & ADOLESCENTDRUG INTERACTIONWith medicine :With food & others :OVER DOSEAcute overdose is very unlikely to occur. However, in the case of chronic over dosage or misuse, the features of hypercorticisms may appear and in this situation topical steroids should be discontinued.STORAGEStore below 300 C and dry place, protected from light. Keep all medicines out of reach of children.PACKINGAclobet Ointment : Each pack contains 10 gm Ointment in tube.Aclobet Cream : Each pack contains 10 gm Cream in tube...
Tk.50.14/=
Aclobet 10 gm cream
Aclobet 10 gm creamCOMPOSITIONAclobet Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg.Aclobet Cream : Each gram contains Clobetasol Propionate BP 0.5 mg.PHARMACOLOGYClobetasol Propionate is a highly potent topical steroid. It has both local anti-inflammatory and immunosuppressive activity. Clobetasol, as the Propionate salt, is only used topically on the skin and its effects are limited to the local anti-inflammatory activity. When given systemically it has standard glucocorticoid activity and binds with high affinity to the glucocorticoid receptor. Clobetasol Propionate inhibits the adherence of neutrophils and monocyte-macrophages to the capillary endothelial cells inflammed area. Clobetasol blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin.INDICATIONSAclobet is indicated in :• Initial control of all forms of hyperacute eczema in all age groups (in children for no longer than a few days).• Chronic hyperkeratotic eczema of the hands and feet and patches of chronic lichen simplex.• Chronic hyperkeratotic psoriasis of any area of the body.• Severe acute photosensitivity.• Hypertrophic lichen planus.• Localized bullous disorders.• Keloid scarring.• Pretibial myxoedema.• Vitiligo.• Suppression of reaction after cryotherapy.DOSAGE AND ADMINISTRATIONRoute of AdministrationApply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations, therapy should be discontinued when control is achieved. If a longer course is necessary, it is recommended that treatment should not be continued for more than four weeks without the patients condition being observed. Repeated short courses of Aclobet may be used to control exacerbations. If continuous steroid treatment is necessary a less potent preparation should be used. In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effects of Aclobet can be enhanced, if necessary, by occluding the treatment area with polythene film. Only overnight occlusion is usually adequate to bring about a satisfactory response. Thereafter, improvement can usually be maintained by application without occlusion.CONTRAINDICATIONS AND PRECAUTIONClobetasol Propionate is contraindicated in :• Cutaneous infections such as impetigo, tinea corporis and herpes simplex.• Infestations such as scabies.• Neonates.• Acne Vulgaris.• Rosacea.• Gravitational ulceration.Long term continuous therapy with Clobetasol Propionate should be avoided, particularly in infants and children, in whom adrenal suppression occurs readily. If Clobetasol Propionate is required for use in children, it is recommended that the treatment should be reviewed on weekly basis. It should be noted that the infant’s napkin might act asocclusive dressing. The face more than other area of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids. This must be borne in mind when treating facial conditions which warrants use of Clobetasol Propionate and frequent observation of the patient is important.SIDE EFFECTSCommon side effects : Provided the weekly dosage is less then 50 g in adults, any pituitary adrenal suppression is likely to be transient with a rapid return to normal values once the short course of steroid therapy has ceased. The same applies to children given proportionate dosage. Use of occlusive dressings increases the absorption of topical corticosteroids. Prolonged and intensive treatment with a highly active corticosteroid preparation may cause atrophic changes, such as thinning, striae and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or where skin folds are involved.Rare side effects :USE IN PREGNANCY & LACTATIONClobetasol Propionate should be avoided in pregnant women. Mothers using large amounts of the drug should be aware of potential excretion in milk.USE IN CHILDREN & ADOLESCENTDRUG INTERACTIONWith medicine :With food & others :OVER DOSEAcute overdose is very unlikely to occur. However, in the case of chronic over dosage or misuse, the features of hypercorticisms may appear and in this situation topical steroids should be discontinued.STORAGEStore below 300 C and dry place, protected from light. Keep all medicines out of reach of children.PACKINGAclobet Ointment : Each pack contains 10 gm Ointment in tube.Aclobet Cream : Each pack contains 10 gm Cream in tube...
Tk.45.13/=
Aclobet-N 15 gm cream
Aclobet-N creamDESCRIPTIONClobetasol Propionate is a highly active corticosteroid with topical antiinflammatory activity. The major effect of Clobetasol Propionate on skin is a nonspecific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.COMPOSITIONAclobet-N Cream : Each gram contains Clobetasol Propionate BP 0.5 mg, Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.Aclobet-N Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg,Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.INDICATIONS AND USAGE Eczema unresponsive to weak steroid cream or ointment. Other inflammatory skin disorders resistant to treatment with weaker steroid cream or ointment . Psoriasis. Any inflammatory skin disorders where secondary bacterial or candidal infection is present, suspected or likely to occur.DOSAGE AND ADMINISTRATIONAdults and children above 2 years : Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved. In very resistant lesions, especially where there is hyperkeratosis, the antiinflammatory effect of this preparation can be enhanced, if necessary, by occluding the treatment area with polythene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patients condition being reviewed. Repeated short courses of Aclobet - N may be used to control exacerbations.Elderly :This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur.Children : Under 2 years this preparation is not recommended.SIDE EFFECTSGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved.CONTRAINDICATIONSIt is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (e.g herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations.PRECAUTIONSLong term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If use in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.USE IN PREGNANCY & LACTATIONThe safe use of this preparation during pregnancy & lactation has not been established.DRUG INTERACTIONSNeomycin sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.OVER DOSEAcute over dosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient’s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate.SUPPLYAclobet-N Cream : Each pack contains 15 gm cream in a tube.Aclobet-N Ointment : Each pack contains 15 gm ointment in a tube..
Tk.60.18/=
Aclobet-N 15 gm Oint
Aclobet-N OintDESCRIPTIONClobetasol Propionate is a highly active corticosteroid with topical antiinflammatory activity. The major effect of Clobetasol Propionate on skin is a nonspecific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.COMPOSITIONAclobet-N Cream : Each gram contains Clobetasol Propionate BP 0.5 mg, Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.Aclobet-N Ointment : Each gram contains Clobetasol Propionate BP 0.5 mg,Neomycin Sulphate USP 5 mg and Nystatin USP 100000 units.INDICATIONS AND USAGE Eczema unresponsive to weak steroid cream or ointment. Other inflammatory skin disorders resistant to treatment with weaker steroid cream or ointment . Psoriasis. Any inflammatory skin disorders where secondary bacterial or candidal infection is present, suspected or likely to occur.DOSAGE AND ADMINISTRATIONAdults and children above 2 years : Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved. In very resistant lesions, especially where there is hyperkeratosis, the antiinflammatory effect of this preparation can be enhanced, if necessary, by occluding the treatment area with polythene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patients condition being reviewed. Repeated short courses of Aclobet - N may be used to control exacerbations.Elderly :This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur.Children : Under 2 years this preparation is not recommended.SIDE EFFECTSGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved.CONTRAINDICATIONSIt is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (e.g herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations.PRECAUTIONSLong term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If use in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.USE IN PREGNANCY & LACTATIONThe safe use of this preparation during pregnancy & lactation has not been established.DRUG INTERACTIONSNeomycin sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.OVER DOSEAcute over dosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient’s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate.SUPPLYAclobet-N Cream : Each pack contains 15 gm cream in a tube.Aclobet-N Ointment : Each pack contains 15 gm ointment in a tube..
Tk.65.45/=
Cenolon Inj.
Cenolon Inj.DescriptionTriamcinolone Acetonide is a synthetic corticosteroid having glucocorticoid activity with marked anti-inflammatory action. Triamcinolone Acetonide has an extended duration of effect which may be permanent, or sustained over a period of several weeks.IndicationsPost-traumatic osteoarthritis, synovitis of osteoarthritis, rheumatoid arthritis, acute and sub-acute bursitis, epicondylitis, acute non-specific tenosynovitis, acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis, bronchial asthma, contact dermatitis, atopic dermatitis, seasonal or perennial allergic rhinitis.Dosage & AdministrationChildren 6 to 12 years: initial dose is 40 mgAdults and children over 12 years of age: initial dose is 60 mg. Dosage is usually adjusted within the range of 40 to 80 mg. For local areas, dose for adults is up to 10 mg for smaller areas and up to 40 mg for larger areas.Side EffectsCushingoid syndrome, weakness, bruising or purpura, aggravation of infections, peptic ulcer, activation of latent or aggravation of existing diabetes, altered menstrual cycle, hirsutism.PrecautionsTriamcinolone Acetonide injection should be used cautiously in patients with ocular herpes simplex, nonspecific ulcerative colitis, active or latent peptic ulcer, renal insufficiency, hypertension, osteoporosis, Cushing's syndrome, diabetes mellitus, congestive heart failure, chronic nephritis.Use in Pregnancy & LactationTriamcinolone Acetonide injection should be used during pregnancy, nursing mothers if the possible benefits of the medication justify the potential hazards to the fetus or nursing infant.Drug InteractionAminoglutethimide: Aminoglutethimide may lead to a loss of corticosteroid-induced adrenal suppression.Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (ie, amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.Anticoagulants, oral: Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.Antidiabetics: Because corticosteroids may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.Antitubercular drugs: Serum concentrations of isoniazid may be decreased.Cholestyramine: Cholestyramine may increase the clearance of corticosteroids.Cyclosporine: Increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently. Convulsions have been reported with this concurrent use.Digitalis glycosides: Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia.Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.Hepatic enzyme inducers (eg, barbiturates, phenytoin, carbamazepine, rifampin): Drugs which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to an increased risk of corticosteroid side effects.Nonsteroidal anti-inflammatory drugs (NSAIDs): Concomitant use of aspirin (or other nonsteroidal anti-inflammatory drugs) and corticosteroids increases the risk of gastrointestinal side effects. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. The clearance of salicylates may be increased with concurrent use of corticosteroids.Skin tests: Corticosteroids may suppress reactions to skin tests.Vaccines: Patients on prolonged corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response. Corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines. Routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is disc..
Tk.75.00/=
Cenolon Nasal Spray
Cenolon Nasal SprayDescriptionTriamcinolone Acetonide is a corticosteroid. It is a more potent derivative of Triamcinolone and approximately 8 times more potent than Prednisone. Although the precise mechanism of corticosteroid antiallergic action is unknown, corticosteroids are very effective.IndicationsCenolon Nasal Spray is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 2 years of age and older.Dosage & AdministrationAdults and children 12 years of age and older: The recommended starting and maximum dose is 220 mcg per day as two sprays in each nostril once daily.Children 2 to 12 years of age: The recommended starting dose is 110 mcg per day given as one spray in each nostril once daily. The maximum recommended dose is 220 mcg per day as two sprays per nostril once daily.Side EffectsGenerally, Triamcinolone Acetonide, is well tolerated. However, few side-effects such as-pharyngitis, epistaxis, increase in cough, headache, infection, sinusitis and vomiting may occur.PrecautionsTriamcinolone Acetonide nasal spray should be used with caution, if at all, in patients with active or quiescent tuberculous infection of the respiratory tract or in patients with untreated fungal, bacterial, or systemic viral infections or ocular herpes simplex. In clinical studies with Triamcinolone Acetonide nasal spray, the development of localized infections of the nose and pharynx with Candida albicans has rarely occurred.Use in Pregnancy & LactationPregnancy: There are no adequate and well-controlled studies in pregnant women. Triamcinolone Acetonide nasal spray, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.Lactation: It is not known whether Triamcinolone Acetonide is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be exercised when Triamcinolone Acetonide nasal spray is administered to nursing women.Over DoseLike any other nasally administered corticosteroids, acute overdosing is unlikely in view of the total amount of active ingredient present. In the event that the entire contents of the bottle were administered all at once, via either oral or nasal application, clinically significant systemic adverse events would most likely not result. The patient may experience some gastrointestinal upseCommercial PackCenolon Nasal Spray: Each bottle contains 120 metered dose spray...
Tk.200.00/=
Clobesol Cream
Clobesol has both local anti-inflammatory and immunosuppressive activity. The drug blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin. Clobesol also reduces the number of human leukocyte antigen & also inhibits phospholipase A2 activity via formation of lipocortin. Clobetasol reduces the formation of prostaglandins and leucotrienes in the local tissues...
Tk.58.00/=
Clobesol Ointment
Clobesol has both local anti-inflammatory and immunosuppressive activity. The drug blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin. Clobesol also reduces the number of human leukocyte antigen & also inhibits phospholipase A2 activity via formation of lipocortin. Clobetasol reduces the formation of prostaglandins and leucotrienes in the local tissues...
Tk.68.00/=
Clobesol SA Ointment
Clobetasol Propionate has both local anti-inflammatory and immunosuppressive activity. The drug blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin. It inhibits phospholipase A2 activity via formation of lipocortin which reduces the formation of prostaglandins and leucotrienes in the local tissues. Salicylic acid is a keratolytic agent. It encourages exfoliation of the skin and opening up of the plugged follicles, which helps re-establish the normal skin-cell replacement cycle...
Tk.70.00/=
Dermasol 0.05% 10g Cream
Dermasol 10g CreamIndication:Eczema, psoriasis, Hypertrophic lichen planus, Localized bullous disorders, Kelold scarring, Pretibial myxoedema, Vitiligo. Suppression of reaction after cryotherapyDosage & Administration:Once or twice daily until improvement occurs, should not be continued for more than four weeksPreparation:Dermasol® 0.05% cream : Tube containing 20 gm cream.Dermasol® 0.05% ointment : Tube containing 20 gm ointment...
Tk.45.31/=
Dermasol 0.05% 10g ointment
Indication:Eczema, psoriasis, Hypertrophic lichen planus, Localized bullous disorders, Kelold scarring, Pretibial myxoedema, Vitiligo. Suppression of reaction after cryotherapyDosage & Administration:Once or twice daily until improvement occurs, should not be continued for more than four weeksPreparation:Dermasol® 0.05% cream : Tube containing 20 gm cream.Dermasol® 0.05% ointment : Tube containing 20 gm ointment...
Tk.75.50/=
Dermasol 0.05% 20g Cream
Indication:Eczema, psoriasis, Hypertrophic lichen planus, Localized bullous disorders, Kelold scarring, Pretibial myxoedema, Vitiligo. Suppression of reaction after cryotherapyDosage & Administration:Once or twice daily until improvement occurs, should not be continued for more than four weeksPreparation:Dermasol® 0.05% cream : Tube containing 20 gm cream.Dermasol® 0.05% ointment : Tube containing 20 gm ointment...
Tk.70.48/=
Dermasol 0.05% 20g Ointment
Indication:Eczema, psoriasis, Hypertrophic lichen planus, Localized bullous disorders, Kelold scarring, Pretibial myxoedema, Vitiligo. Suppression of reaction after cryotherapyDosage & Administration:Once or twice daily until improvement occurs, should not be continued for more than four weeksPreparation:Dermasol® 0.05% cream : Tube containing 20 gm cream.Dermasol® 0.05% ointment : Tube containing 20 gm ointment...
Tk.75.50/=
Dermasol-N Cream 15 gm tube
Dermasol N CreamIndication:• Eczema, Neurodermatoses, Psoriasis where secondary bacterial infection or fungal infection is present, suspected or likely to occur• Other inflammatory conditions which do not respond satisfactorily to less active steroidsPreparation:Dermasol-N® Cream: Each pack has a tube containing 15 gm cream.Dermasol-N® Ointment: Each pack has a tube containing 15 gm ointment...
Tk.70.21/=
Dermasol-N Ointment 15 gm tube
Indication:• Eczema, Neurodermatoses, Psoriasis where secondary bacterial infection or fungal infection is present, suspected or likely to occur• Other inflammatory conditions which do not respond satisfactorily to less active steroidsPreparation:Dermasol-N® Cream: Each pack has a tube containing 15 gm cream.Dermasol-N® Ointment: Each pack has a tube containing 15 gm ointment...
Tk.75.22/=
Dermasol-S 0.05% Scalp Solution 25 ml bottle
Indication:It is indicated in the topical therapy of recalcitrant corticosteroid-responsive dermatoses of the scalp, including recalcitrant cases of psoriasis and seborrheic dermatitisDosage & Administration:Apply required quantity of spray once or twice daily to the affected areas of the scalp and gently rub inPreparation:Each container contains 25 ml Solution..
Tk.200.61/=
Dermex NN 20gm
Dermex NN 20gmClobetasol Propionate + Neomycin Sulphate + Nystatin(0.5 mg+5 mg+1 Lac IU)..
Tk.80.00/=
Exovate Cream
Clobetasol Propionate is a very active topical corticosteroid which is of particular value when used in short courses for the treatment of more resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas and other conditions which do not respond satisfactorily to less active steroids.A small quantity should be applied to the affected area once or twice daily until improvement occurs. Therapy should be discontinued when control is achieved. It is recommended that treatment should not be continued for more than two or four weeks without the patients’ condition being reviewed.Highly potent than other corticosteroidsProvides confidence in treating all moderate to severe dermatosesEnsures better treatment in all types of skin infections..
Tk.45.00/=
Exovate N cream
Clobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific antiinflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. The use of Nystatin in the local treatment of candidal infections of the skin and of Neomycin as a broad-spectrum antibiotic is well known.Exovate® N cream is indicated in more resistant dermatoses such as recalcitrant eczemas and psoriasis (excluding widespread plaque psoriasis) where secondary bacterial or candidal infection is present, suspected or likely to occur, as when using occlusive dressings.Effective against non-responsive dermatosesEffective against allergic and pruritic conditionsEffective against bacterial and fungal skin infections..
Tk.90.00/=
Exovate N Ointment
Exovate N OintmentClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific antiinflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. The use of Nystatin in the local treatment of candidal infections of the skin and of Neomycin as a broad-spectrum antibiotic is well known.Exovate® N cream is indicated in more resistant dermatoses such as recalcitrant eczemas and psoriasis (excluding widespread plaque psoriasis) where secondary bacterial or candidal infection is present, suspected or likely to occur, as when using occlusive dressings.Effective against non-responsive dermatosesEffective against allergic and pruritic conditionsEffective against bacterial and fungal skin infections..
Tk.100.00/=
Exovate Ointment
Exovate OintmentClobetasol Propionate is a very active topical corticosteroid which is of particular value when used in short courses for the treatment of more resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas and other conditions which do not respond satisfactorily to less active steroids.A small quantity should be applied to the affected area once or twice daily until improvement occurs. Therapy should be discontinued when control is achieved. It is recommended that treatment should not be continued for more than two or four weeks without the patients’ condition being reviewed.Highly potent than other corticosteroidsProvides confidence in treating all moderate to severe dermatosesEnsures better treatment in all types of skin infections..
Tk.50.00/=
Kerasol 12% Cream
Kerasol 12% CreamDescriptionkerasol is available by prescription only as a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris and psoriasis (including body, scalp, palms and soles).IndicationsKerasol (6% Salicylic Acid) topical preparations treat the following common scaly conditions:- Chronic atopic dermatitis- Lichen simplex- Psoriasis- Seborrhoeic dermatitis- IchthiosisKerasol (12% Salicylic Acid) topical preparations treat the following common scaly conditions:- Warts (small excessive growths of skin caused by a type of virus. Warts often occur on the fingers or on the back of the hands).- Verruca (occurs only on the sole of the feet and can be painful. It often looks like a small white ring of skin with a black dot in the centre.- Corns and Calluses (are hard, thick pads of skin caused by pressure and friction. They usually occur on the feet due to poorly fitting shoes and can occur on the hands).Dosage & AdministrationApply to affected area once daily. Hydrate area for 5 minutes prior to application if possible. Occlude the area at night. Wash off in morning. Salicylic Acid is used in children over 2 years.Side EffectsAn allergic reaction (shortness of breath, closing of the throat, swelling of the lips, face or tongue or hives) or severe skin irritation.PrecautionsFor external use only. Avoid contact with eyes and other mucous membranes.Use in Pregnancy & LactationPregnancy: Pregnancy Category C.Lactation: If used by nursing mothers, it should not be used on the chest area to avoid accidental contamination of the child.Drug InteractionDo not use other topical preparations on the treated area unless otherwise directed by your healthcare provider. They may interfere with treatment or increase skin irritation.Over DoseAn overdose of Salicylic Acid topical is unlikely to occur. If you do suspect an overdose or if the medication has been ingested, call a poison control center or emergency room for advice.StorageStore at a temperature below 25 °C...
Tk.110.00/=
Kerasol 6% Cream
Kerasol 6% CreamDescriptionkerasol is available by prescription only as a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris and psoriasis (including body, scalp, palms and soles).IndicationsKerasol (6% Salicylic Acid) topical preparations treat the following common scaly conditions:- Chronic atopic dermatitis- Lichen simplex- Psoriasis- Seborrhoeic dermatitis- IchthiosisKerasol (12% Salicylic Acid) topical preparations treat the following common scaly conditions:- Warts (small excessive growths of skin caused by a type of virus. Warts often occur on the fingers or on the back of the hands).- Verruca (occurs only on the sole of the feet and can be painful. It often looks like a small white ring of skin with a black dot in the centre.- Corns and Calluses (are hard, thick pads of skin caused by pressure and friction. They usually occur on the feet due to poorly fitting shoes and can occur on the hands).Dosage & AdministrationApply to affected area once daily. Hydrate area for 5 minutes prior to application if possible. Occlude the area at night. Wash off in morning. Salicylic Acid is used in children over 2 years.Side EffectsAn allergic reaction (shortness of breath, closing of the throat, swelling of the lips, face or tongue or hives) or severe skin irritation.PrecautionsFor external use only. Avoid contact with eyes and other mucous membranes.Use in Pregnancy & LactationPregnancy: Pregnancy Category C.Lactation: If used by nursing mothers, it should not be used on the chest area to avoid accidental contamination of the child.Drug InteractionDo not use other topical preparations on the treated area unless otherwise directed by your healthcare provider. They may interfere with treatment or increase skin irritation.Over DoseAn overdose of Salicylic Acid topical is unlikely to occur. If you do suspect an overdose or if the medication has been ingested, call a poison control center or emergency room for advice.StorageStore at a temperature below 25 °C...
Tk.65.00/=
Nyclobate Cream 10mg
Nyclobate CreamDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis.Indications• Eczema unresponsive to weak steroid cream or ointment• Other inflammatory skin disorders resistant to treatment with weaker steroid creams or ointment• Psoriasis.Dosage & AdministrationNyclobate Cream & OintmentAdults and children over 1 year:• Apply sparingly to cover the affected area, and gently rub into the skin. Frequency of application is 2 to 3 times daily according to the severity of the condition. The total dose applied should not exceed 50 g weekly.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient\\\'s condition being reviewed.• Repeated short courses of Clobetasol may be used to control exacerbationsChildren below 1 year: Under 1 year this preparation is not recommendedNyclobate Scalp Application• It should be applied to the affected scalp areas twice daily, once in morning and once at night.• Total dosage should not exceed 50 ml per week.• As with other highly active topical steroid preparations, therapy should be discontinued when control is achievedChildren: Under 1 year this preparation is not recommended.Nyclobate Shampoo• It should be applied to the dry (not wet) scalp once a day to the affected areas only.• It should be massaged gently into the lesions and left in place for 15 minutes before lathering and rinsing.• Treatment should be limited to 4 consecutive weeks.• Total dosage of shampoo should not exceed 50 g per week.• Under 18 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNo hazardous interactions have been reported with use of Clobetasol Propionate.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually...
Tk.45.00/=
Nyclobate NN Cream 10g
Nyclobate NN Cream 10gDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.IndicationsAny inflammatory skin disorders like eczema & psoriasis where secondary bacterial or fungal infection is present, suspected or likely to occur.Dosage & AdministrationAdults and children over 2 years:• Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved.• In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effect of this preparaton can be enhanced, if necessary, by occluding the treatment area with polythene.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient's condition being reviewed.• Repeated short courses of Nyclobate NN may be used to control exacerbationsElderly: This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of Neomycin Sulphate may occur.Children: Under 2 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important. Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNeomycin Sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption. However, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient\\\\\\\'s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate...
Tk.60.00/=
Nyclobate NN Cream 20g
Nyclobate NN Cream 20gDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis. Neomycin Sulphate is a broad spectrum antibiotic of the aminoglycoside type and is used to treat infections with bacteria. Nystatin is an antifungal medicine that kills fungi and yeasts by interfering with their cell membranes. The principle action of the preparation is based on the anti-inflammatory activity of the corticosteroid. The broad spectrum antibacterial and anti-candidal activity provided by the combination of Neomycin and Nystatin allow this effect to be utilized in the treatment of conditions which are or are likely to become infected.IndicationsAny inflammatory skin disorders like eczema & psoriasis where secondary bacterial or fungal infection is present, suspected or likely to occur.Dosage & AdministrationAdults and children over 2 years:• Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved.• In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effect of this preparaton can be enhanced, if necessary, by occluding the treatment area with polythene.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient's condition being reviewed.• Repeated short courses of Nyclobate NN may be used to control exacerbationsElderly: This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of Neomycin Sulphate may occur.Children: Under 2 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important. Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNeomycin Sulphate can intensify and prolong the respiratory depressant effects of neuromuscular blocking agents following significant systemic absorption. However, if used in accordance with the recommendations systemic exposure to Neomycin Sulphate is expected to be minimal and drug interactions are unlikely to be significant. No hazardous interactions have been reported with use of Clobetasol Propionate or Nystatin.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually. Also, consideration should be given to significant systemic absorption of Neomycin Sulphate. If this is suspected, use of the product should be stopped and the patient\\\\\\\'s general status, hearing acuity, renal and neuromuscular functions should be monitored. Haemodialysis may reduce the serum level of Neomycin Sulphate...
Tk.80.00/=
Nyclobate Ointment 20 gm
Nyclobate Ointment 20 gmDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis.Indications• Eczema unresponsive to weak steroid cream or ointment• Other inflammatory skin disorders resistant to treatment with weaker steroid creams or ointment• Psoriasis.Dosage & AdministrationNyclobate Cream & OintmentAdults and children over 1 year:• Apply sparingly to cover the affected area, and gently rub into the skin. Frequency of application is 2 to 3 times daily according to the severity of the condition. The total dose applied should not exceed 50 g weekly.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient\\\'s condition being reviewed.• Repeated short courses of Clobetasol may be used to control exacerbationsChildren below 1 year: Under 1 year this preparation is not recommendedNyclobate Scalp Application• It should be applied to the affected scalp areas twice daily, once in morning and once at night.• Total dosage should not exceed 50 ml per week.• As with other highly active topical steroid preparations, therapy should be discontinued when control is achievedChildren: Under 1 year this preparation is not recommended.Nyclobate Shampoo• It should be applied to the dry (not wet) scalp once a day to the affected areas only.• It should be massaged gently into the lesions and left in place for 15 minutes before lathering and rinsing.• Treatment should be limited to 4 consecutive weeks.• Total dosage of shampoo should not exceed 50 g per week.• Under 18 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNo hazardous interactions have been reported with use of Clobetasol Propionate.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually...
Tk.75.00/=
Nyclobate Scalp Application
Nyclobate Scalp ApplicationDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis.Indications• Eczema unresponsive to weak steroid cream or ointment• Other inflammatory skin disorders resistant to treatment with weaker steroid creams or ointment• Psoriasis.Dosage & AdministrationNyclobate Cream & OintmentAdults and children over 1 year:• Apply sparingly to cover the affected area, and gently rub into the skin. Frequency of application is 2 to 3 times daily according to the severity of the condition. The total dose applied should not exceed 50 g weekly.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient\\\'s condition being reviewed.• Repeated short courses of Clobetasol may be used to control exacerbationsChildren below 1 year: Under 1 year this preparation is not recommendedNyclobate Scalp Application• It should be applied to the affected scalp areas twice daily, once in morning and once at night.• Total dosage should not exceed 50 ml per week.• As with other highly active topical steroid preparations, therapy should be discontinued when control is achievedChildren: Under 1 year this preparation is not recommended.Nyclobate Shampoo• It should be applied to the dry (not wet) scalp once a day to the affected areas only.• It should be massaged gently into the lesions and left in place for 15 minutes before lathering and rinsing.• Treatment should be limited to 4 consecutive weeks.• Total dosage of shampoo should not exceed 50 g per week.• Under 18 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNo hazardous interactions have been reported with use of Clobetasol Propionate.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually...
Tk.200.00/=
Nyclobate Shampoo 60 ml
Nyclobate Shampoo 60 mlDescriptionClobetasol Propionate is a highly active corticosteroid with topical anti-inflammatory activity. The major effect of Clobetasol Propionate on skin is a non-specific anti-inflammatory response, partially due to vasoconstriction and decrease in collagen synthesis.Indications• Eczema unresponsive to weak steroid cream or ointment• Other inflammatory skin disorders resistant to treatment with weaker steroid creams or ointment• Psoriasis.Dosage & AdministrationNyclobate Cream & OintmentAdults and children over 1 year:• Apply sparingly to cover the affected area, and gently rub into the skin. Frequency of application is 2 to 3 times daily according to the severity of the condition. The total dose applied should not exceed 50 g weekly.• Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient\\\'s condition being reviewed.• Repeated short courses of Clobetasol may be used to control exacerbationsChildren below 1 year: Under 1 year this preparation is not recommendedNyclobate Scalp Application• It should be applied to the affected scalp areas twice daily, once in morning and once at night.• Total dosage should not exceed 50 ml per week.• As with other highly active topical steroid preparations, therapy should be discontinued when control is achievedChildren: Under 1 year this preparation is not recommended.Nyclobate Shampoo• It should be applied to the dry (not wet) scalp once a day to the affected areas only.• It should be massaged gently into the lesions and left in place for 15 minutes before lathering and rinsing.• Treatment should be limited to 4 consecutive weeks.• Total dosage of shampoo should not exceed 50 g per week.• Under 18 years this preparation is not recommended.Side EffectsGenerally this preparation is well tolerated. However, few side effects after prolonged and intensive treatment may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used, or when skin folds are involved.PrecautionsLong-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important.Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame.Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye.Use in Pregnancy & LactationPregnancy category C: The safe use of this preparation during pregnancy & lactation has not been established.Drug InteractionNo hazardous interactions have been reported with use of Clobetasol Propionate.Over DoseAcute overdosage is very unlikely to occur, however, in the case of chronic overdosage or misuse the features of hypercortisolism may appear and in this situation topical steroids should be discontinued gradually...
Tk.350.00/=
Splendora 5% Scalp Lotion
Indication:SplendoraTM is indicated for the treatment of alopecia androgenetica (hair loss) in males and females between 18 to 65 years of age.Dosage and Administration: SplendoraTM topical solution is for external use only and should be applied when the hair and scalp are clean and dry. Apply 1 ml (7 sprays) of SplendoraTM topical solution twice daily at 12-hour intervals to the scalp, beginning at the centre of the affected area and spreading the solution out to cover the entire affected area. The total daily application dose should not exceed 2 ml.For the best results, Splendora™ topical solution should be allowed to remain on the scalp for about 4 hours before washing. The night-time application should be done 2–4 hours before going to bed to allow the solution to dry out. Splendora™ topical solution should not be massaged into the scalp, but applied lightly. A hair dryer should not be used to speed up the drying of the solution as it may decrease the effectiveness. Splendora™ topical solution should not be mixed with any hair oil. The drug should not be used more than two times a day, or be taken orally or applied to any other part of the body to avoid the risk of adverse effects and unwanted hair growth. More frequent use or longer application time have no effect on hair growth. In case of missing any daily applications of SplendoraTM topical solution, the patient should continue with the next application.Hands should be washed immediately if Minoxidil topical solution is applied with the fingertips. Clinical experience with SplendoraTM indicates that twice-daily applications for 4 months or more may be required before there is evidence of hair growth. To arrest hair fall, SplendoraTM topical solution should be used for not less than 45 days. Depending upon the severity of hair loss or type and extent of baldness, particular strength of SplendoraTM topical solution may be selected.Preparation:SplendoraTM 5%: Each pack contains 60 ml solution in HDPE container...
Tk.601.81/=